How I manage patients with hairy cell leukaemia.

about

MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab.Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

P2860

Q48334420-30AE13CA-06D2-405A-AFB8-C9585276FFB3 Q55025278-51B19949-2353-482A-90F0-C9221A428421 Q56355787-1FC8810A-9A04-4A29-8A42-6D97CACE867F

P2860

How I manage patients with hairy cell leukaemia.

Item

http://www.wikidata.org/entity/Q39113513

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

How I manage patients with hairy cell leukaemia.

@en

How I manage patients with hairy cell leukaemia.

@nl

type

Item

label

How I manage patients with hairy cell leukaemia.

@en

How I manage patients with hairy cell leukaemia.

@nl

prefLabel

How I manage patients with hairy cell leukaemia.

@en

How I manage patients with hairy cell leukaemia.

@nl

P1476

How I manage patients with hairy cell leukaemia.

@en

P2093

Philip A Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations in hairy-cell leukemia

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients.

Treatment of hairy cell leukemia-variant with cladribine.

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.

P304

543-556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14524

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Farhad Ravandi

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28146266

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

How I manage patients with hairy cell leukaemia.

about

P2860

P2860

How I manage patients with hairy cell leukaemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921